BrandEseence Logo

Anemia Drugs Market

Anemia Drugs Market Size, Share & Trends Analysis Report

Anemia Drugs Market Overview & Potential Growth Opportunities 2020-2025

Published
Report ID : BMRC 448
Number of pages : 300
Published Date : Nov 2022
Category : Healthcare
Delivery Timeline : 48 hrs

Anemia Drugs Market report is segmented on the basis of anemia type, end-user and region & country level. Based upon anemia type, global anemia drugs market is segmented into iron deficiency anemia, sickle cell anemia, aplastic anemia, hemolytic anemia, pernicious anemia and others. Based on end-user, the anemia drugs market is segmented into hospitals, private clinics and other.

Anemia Drugs Market is valued at USD 26292.3 Million in 2018 and expected to reach USD 55279.2 Million by 2025 with the CAGR of 11.20% over the forecast period.

Market Analysis of Anemia Drugs-

Anemia is a set of conditions characterized by weakness, shortness of breath and a general tiredness due to a decrease in the total amount of red blood cells (RBCs) or hemoglobin in the blood. Anemia is a common cause of qualitative or quantitative deficiency of hemoglobin. Hemoglobin is iron rich protein that carries the oxygen from lungs to the other parts of body tissue. The hemoglobin deficiency is generally associated with the decrease in the number of red blood cells and hematocrit. Anemia causes low transfer of oxygen to the rest of the body. It is easily preventable and treated however, there are mild or vague symptoms for detection of anemia due to which anemia mostly goes undetectable.

The regions covered in this Global Anemia Drugs Market report are North America, Europe, Asia-Pacific and Rest of the World. On the basis of country level, the market of anemia drugs is sub divided into U.S., Mexico, Canada, U.K., France, Germany, Italy, China, Japan, India, South East Asia, Middle East Asia (UAE, Saudi Arabia, Egypt) GCC, Africa, etc.

Key Players -

Some of the key players in Global Anemia Drugs market are:

  • Amgen Inc.
  • Meda Cuonsumer Healthcare Inc.
  • Johnson and Johnson
  • Emmaus Medical Inc.
  • Keryx Biopharmaceuticals Inc.
  • Abbvie Inc
  • GlaxoSmithKline plc
  • Pfizer Inc.
  • Allergan Inc.
  • Hoffmann La Roche AG
  • others

High Prevalence of Anemia is One of the Major Factors Driving the Growth of Global Anemia Drugs Market.

The increasing rate of nutritional deficiency is one of the major driving factors of anemia drugs market  globally. The increase in prevalence of chronic diseases and unhealthy life styles and growing baby bloomer population are some of the factors boosting the growth of anemia drugs market. In addition, increasing government initiatives in improving the healthcare facilities in developing countries is also supplementing the market growth.  However, adverse effects associated with the medications of anemia drugs may hamper the market growth. Moreover, increasing research and development associated with the anemia drugs can create new opportunities for the market growth of anemia drugs during the forecast period. Furthermore, the highest number of individuals affected with anemia after pre-school-age children are non-pregnant women which are around 31.2% of the total anemic population. As per WHO, globally anaemia affects 1.62 billion people, which corresponds to 24.8% of the population. The highest prevalence is in preschool-age children and the lowest prevalence is in men. However, the population group with the greatest number of individuals affected is non-pregnant women.

North America is expected to Dominate the Anemia Drug Market.

By region, the global anemia drugs market has been segmented into North America, Europe, Asia Pacific, and the Middle East & Africa. Globally, North America is the largest market for anemia drugs owing to increasing healthcare infrastructure and  advanced technology, high research activities and growing awareness about anemia in this region. Asia pacific region is anticipated to show  the fastest growth due to increasing health care expenditure and disposable income, high prevalence of chronic diseases and increasing geriatric population.

Key Benefits for Market Reports –

  • Global market report covers in depth historical and forecast analysis.
  • Global market research report provides detail information about Market Introduction, Market Summary, Global market Revenue (Revenue USD), Market Drivers, Market Restraints, Market opportunities, Competitive Analysis, Regional and Country Level.
  • Global market report helps to identify opportunities in market place.
  • Global market report covers extensive analysis of emerging trends and competitive landscape.

Market Segmentation:-

By Anemia Type:

  • Iron Deficiency Anemia
  • Sickle Cell Anemia
  • Aplastic Anemia
  • Hemolytic Anemia
  • Pernicious Anemia
  • Others

By End-User:

  • Hospitals
  • Private Clinics
  • Others

By Regional & Country Level:

  • North America
    • US.
    • Canada
  • Europe
    • UK.
    • France
    • Germany
    • Italy
  • Asia Pacific
    • China
    • Japan
    • India
    • Southeast Asia
  • Latin America
    • Brazil
    • Mexico
  • Middle East and Africa
    • GCC
    • Africa
    • Rest of Middle East and Africa
SUMMARY
VishalSawant
Vishal Sawant
Business Development
vishal@brandessenceresearch.com
+91 8830 254 358
Segmentation
Segments
A B C
Country
Regions and Country

North America

  • U.S.
    U.S.
  • Canada
    Canada

Europe

  • Germany
    Germany
  • France
    France
  • U.K.
    U.K.
  • Italy
    Italy
  • Spain
    Spain
  • Sweden
    Sweden
  • Netherlands
    Netherlands
  • Turkey
    Turkey
  • Switzerland
    Switzerland
  • Belgium
    Belgium
  • Rest of Europe

Asia-Pacific

  • South Korea
    South Korea
  • Japan
    Japan
  • China
    China
  • India
    India
  • Australia
    Australia
  • Philippines
    Philippines
  • Singapore
    Singapore
  • Malaysia
    Malaysia
  • Thailand
    Thailand
  • Indonesia
    Indonesia
  • Rest of APAC

Latin America

  • Mexico
    Mexico
  • Colombia
    Colombia
  • Brazil
    Brazil
  • Argentina
    Argentina
  • Peru
    Peru
  • Rest of South America

Middle East and Africa

  • Saudi Arabia
    Saudi Arabia
  • UAE
    UAE
  • Egypt
    Egypt
  • South Africa
    South Africa
  • Rest of MEA
Company
Key Players
  • Amgen Inc.
  • Meda Cuonsumer Healthcare Inc.
  • Johnson and Johnson
  • Emmaus Medical Inc.
  • Keryx Biopharmaceuticals Inc.
  • Abbvie Inc
  • GlaxoSmithKline plc
  • Pfizer Inc.
  • Allergan Inc.
  • Hoffmann La Roche AG
  • others

+44-1173181773

sales@brandessenceresearch.com

We are always looking to hire talented individuals with equal and extraordinary proportions of industry expertise, problem solving ability and inclination interested? please email us hr@brandessenceresearch.com

JOIN US

LONDON OFFICE

BrandEssence® Market Research and Consulting Pvt ltd.

124, City Road, London EC1V 2NX

FOLLOW US

Twitter
Facebook
LinkedIn
Skype
YouTube

CONTACT US

1-888-853-7040 - U.S. (TOLL FREE)
+44-1173181773 - U.K. OFFICE
+91-7447409162 - INDIA OFFICE

© Copyright 2023-24 BrandEssence® Market Research and Consulting Pvt ltd. All Rights Reserved | Designed by BrandEssence®

PaymentModes